Background: Myasthenia gravis is characterized by weakness and fatigability of different muscle groups, including ocular, bulbar and the limbs. Therefore, a measure of disease severity at the impairment level in myasthenia needs to reflect all the relevant impairments, as well as their variations with activity and fatigue. We conducted a qualitative study of patients with myasthenia, to explore their experiences and related impairments, aimed at developing a conceptual framework of disease severity at the impairment level in myasthenia gravis. Methods: Twenty patients representing the spectrum of disease participated in semi-structured interviews. Interviews were recorded and the transcripts were analyzed by content analysis using an induct...
Diagnosis Clinical Criteria are the most important. The history of fluctuation of symptoms should ma...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Myasthenia Gravis (MG) is a chronic autoimmune disease affecting the neuromuscular junction. Althoug...
Background: Myasthenia gravis is characterized by weakness and fatigability of different muscle grou...
Objectives: The aim of this dissertation was to develop a measure of the impairments in patients wit...
<p>This diagram depicts our proposed framework of disease severity at the impairment level, in myast...
†<p>Both impairments are combined in a single item.</p>¶<p>Unclear whether it is patient reported.</...
Abstract Background Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease, characteri...
Introduction: The recently developed Myasthenia Gravis Impairment Index (MGII) is a promising measur...
BACKGROUND The subjective feeling of fatigue in myasthenia gravis (MG) is poorly elucidated, in par...
Research tasks: 1. To evaluate demographic parameters in patients with myasthenia gravis. 2. To eval...
Myasthenia gravis is characterized by weakness and rapid fatigue of any of the muscles under your vo...
Aim: During the past decade, there has been an increasing interest in the evaluation of cognitive fu...
Ocular Myasthenia Gravis (OMG) causes ptosis and diplopia, which can be disabling. The rating scales...
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder in which disabling muscle weakness ma...
Diagnosis Clinical Criteria are the most important. The history of fluctuation of symptoms should ma...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Myasthenia Gravis (MG) is a chronic autoimmune disease affecting the neuromuscular junction. Althoug...
Background: Myasthenia gravis is characterized by weakness and fatigability of different muscle grou...
Objectives: The aim of this dissertation was to develop a measure of the impairments in patients wit...
<p>This diagram depicts our proposed framework of disease severity at the impairment level, in myast...
†<p>Both impairments are combined in a single item.</p>¶<p>Unclear whether it is patient reported.</...
Abstract Background Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disease, characteri...
Introduction: The recently developed Myasthenia Gravis Impairment Index (MGII) is a promising measur...
BACKGROUND The subjective feeling of fatigue in myasthenia gravis (MG) is poorly elucidated, in par...
Research tasks: 1. To evaluate demographic parameters in patients with myasthenia gravis. 2. To eval...
Myasthenia gravis is characterized by weakness and rapid fatigue of any of the muscles under your vo...
Aim: During the past decade, there has been an increasing interest in the evaluation of cognitive fu...
Ocular Myasthenia Gravis (OMG) causes ptosis and diplopia, which can be disabling. The rating scales...
Myasthenia gravis (MG) is an autoimmune neuromuscular disorder in which disabling muscle weakness ma...
Diagnosis Clinical Criteria are the most important. The history of fluctuation of symptoms should ma...
Myasthenia gravis (MG) is an autoantibody-mediated disease that compromises the acetylcholine recept...
Myasthenia Gravis (MG) is a chronic autoimmune disease affecting the neuromuscular junction. Althoug...